Fig. 2From: B4GALT5 high expression associated with poor prognosis of hepatocellular carcinomaSurvival analysis of B4GALT5 combined with clinicopathological parameters on TCGA cohort. (a-d) Kaplan-CMeier curves according to B4GALT5 signature with age ≥ 60, female, white, stage I-II patients in GSE14520 cohort(p<0.05). (e-h) Kaplan-CMeier curves of B4GALT5 signature with age ≥ 60, male, low ALT and cirrhosis patients in TCGA cohort(p<0.05)Back to article page